Patent · US Active

Method for diagnosing and assessing endometriosis

US11965879B2 · kind B2 · utility

0Cited by
0References
17Claims
0Family size

Assignee

Inventor

Key dates

Filing dateAug 21, 2020
Grant dateApr 23, 2024
Priority date
Expiry dateFeb 4, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/364
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of detecting the expression level of miRNA markers in a biological sample obtained from a mammal is provided. The method incudes the steps of i) detecting the expression level of one or more miRNA markers selected from the group of miR-199a-3p, miR-143-3p, miR-340-5p, let-7b-5p, miR-21-5p, miR-17-5p, miR-20a-5p and miR-103a-3p, in the biological sample; ii) detecting the expression level of at least one miRNA reference marker selected from miR-148b-3p and miR-30e-5p in the biological sample; and iii) normalizing the expression level of the miRNA marker(s) against the expression level of the miRNA reference marker in the sample and in a control. The method is useful for the diagnosis of endometriosis, monitoring of patient response to treatment, and assessment of disease progression and/or severity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.